Home » Topics » BioWorld Science

BioWorld Science
RSS

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Cypros seeks broad international patent coverage for CPC-111

Sep. 27, 1996

Tyrosine kinase inhibitors from Warner-Lambert

Sep. 27, 1996

Bayer investigates agents for arteriosclerosis, restenosis

Sep. 27, 1996

Novel free radical scavengers reported by Merrell

Sep. 27, 1996

Improved dopaminergic agents from Zambon for cardiovascular disorders

Sep. 27, 1996

Dual ACE/NEP inhibitors from ADIR

Sep. 27, 1996

Mitsui's Na+/H+-exchange inhibitors for cardiovascular disorders

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...